Panacea Biotec Limited has scheduled a meeting of its Board of Directors on Friday, May 29, 2026, at New Delhi. The primary agenda of the meeting is to consider and approve the Audited Financial Results for both the Quarter and Financial Year ended March 31, 2026.
During the same meeting, the Board may also consider matters relating to the recommendation or passing over of dividend on equity shares as well as preference shares for the financial year ended March 31, 2026.
The company has complied with Regulation 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 by uploading the notice of this board meeting on the company's website.
Regarding the trading window closure, the company references its earlier announcement dated March 24, 2026, which intimated the closure of the trading window pursuant to the Company's Code of Conduct for Prevention of Insider Trading. The trading window remains closed for all Designated Persons (including their Immediate Relatives) of the Company from April 01, 2026, until May 31, 2026. The trading window will reopen from June 01, 2026.